Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 3. Radioactive Iodine Therapy in Advanced Thyroid Cancer 2024-Reference-Cited by-同舟云学术

Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 3. Radioactive Iodine Therapy in Advanced Thyroid Cancer 2024

Published:2024-05-30 Issue:1 Volume:17 Page:153-167
ISSN:2384-3799
Container-title:International Journal of Thyroidology
language:en
Short-container-title:Int J Thyroidol

Author:

Kim Keunyoung¹^ORCID,Hong Chae Moon²^ORCID,Kang Ho-Cheol³^ORCID,Kim Sun Wook⁴^ORCID,Na Dong Gyu⁵^ORCID,Park Sohyun⁶^ORCID,Park Young Joo⁷^ORCID,Bang Ji-In⁸^ORCID,Seo Youngduk⁹^ORCID,Song Young Shin¹⁰^ORCID,Lee Sang-Woo¹¹^ORCID,Lee Eun Kyung¹²^ORCID,Lim Dong-Jun¹³^ORCID,Chong Ari¹⁴^ORCID,Chung Yun Jae¹⁵^ORCID,Oh So Won¹⁶^ORCID,

Affiliation:

1. Department of Nuclear Medicine, Pusan National University Hospital, Busan, Korea

2. Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu, Korea

3. Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea

4. Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

5. Department of Radiology, Gangneung Asan Hospital, Gangneung, Korea

6. Department of Nuclear Medicine, National Cancer Center, Goyang, Korea

7. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

8. Department of Nuclear Medicine, CHA Bundang Medical Center, Seongnam, Korea

9. Department of Nuclear Medicine, Chungnam National University Sejong Hospital, Sejong, Korea

10. Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea

11. Department of Nuclear Medicine, Kyungpook National University Chilgok Hospital, Daegu, Korea

12. Department of Internal Medicine, National Cancer Center, Goyang, Korea

13. Department of Internal Medicine, Seoul St. Mary’s Hospital, Seoul, Korea

14. Department of Nuclear Medicine, Chosun University Hospital, Gwangju, Korea

15. Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea

16. Department of Nucelar Medicine, Seoul National University Boramae Medical Center, Seoul, Korea

Funder

Korean Thyroid Association

Publisher

Korean Thyroid Association

Link

https://pdf.medrang.co.kr/IJT/2024/017/ijt-17-1-153.pdf

Reference126 articles.

1. Avram AM, Giovanella L, Greenspan B, Lawson SA, Luster M, Van Nostrand D, et al. SNMMI procedure standard/EANM practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version. J Nucl Med 2022;63(6):15N-35N.

2. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation

4. Disease Severity and Radioactive Iodine Use for Thyroid Cancer

5. The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer